Wilkins Investment Counsel Inc Pfizer Inc Transaction History

Wilkins Investment Counsel Inc

$663 Million
Q2 2024

A detailed history of Wilkins Investment Counsel Inc transactions in Pfizer Inc stock. As of the latest transaction made, Wilkins Investment Counsel Inc holds 261,234 shares of PFE stock, worth $7.25 Million. This represents 1.1% of its overall portfolio holdings.

Number of Shares

261,234

Previous 257,051 1.63%

Holding current value

$7.25 Million

Previous $7.13 Million 2.47%

% of portfolio

1.1%

Previous 1.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	BUY	$25.26 - $29.6 $105,662 - $123,816	4,183 Added 1.63%	261,234 $7.31 Million
Q1 2024 May 09, 2024	BUY	$25.89 - $29.73 $3.98 Million - $4.58 Million	153,890 Added 149.17%	257,051 $7.13 Million
Q4 2023 Feb 12, 2024	BUY	$26.13 - $33.94 $26,130 - $33,940	1,000 Added 0.98%	103,161 $2.97 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $22,077 - $25,806	-688 Reduced 0.67%	102,161 $3.39 Million
Q2 2023 Aug 07, 2023	SELL	$36.12 - $41.79 $267,288 - $309,246	-7,400 Reduced 6.71%	102,849 $3.77 Million
Q1 2023 May 08, 2023	BUY	$39.39 - $51.28 $23,634 - $30,768	600 Added 0.55%	110,249 $4.5 Million
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $13,151 - $17,167	-315 Reduced 0.29%	109,649 $5.62 Million
Q2 2022 Aug 08, 2022	SELL	$46.53 - $55.17 $116,325 - $137,925	-2,500 Reduced 2.22%	109,964 $5.77 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $59,795 - $74,093	-1,307 Reduced 1.15%	112,464 $5.82 Million
Q4 2021 Feb 10, 2022	SELL	$41.32 - $61.25 $41,320 - $61,250	-1,000 Reduced 0.87%	113,771 $6.72 Million
Q2 2021 Jul 30, 2021	SELL	$35.91 - $40.68 $21,545 - $24,408	-600 Reduced 0.52%	114,771 $4.49 Million
Q1 2021 May 10, 2021	SELL	$33.49 - $37.77 $127,262 - $143,526	-3,800 Reduced 3.19%	115,371 $4.18 Million
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $83,675 - $106,400	-2,500 Reduced 2.05%	119,171 $4.39 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $12,048 - $14,616	-400 Reduced 0.33%	121,671 $3.98 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $57,276 - $81,835	-2,119 Reduced 1.71%	122,071 $3.98 Million
Q3 2019 Nov 08, 2019	BUY	$32.49 - $42.13 $25,992 - $33,704	800 Added 0.65%	124,190 $4.46 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $103,543 - $116,256	-2,800 Reduced 2.22%	123,390 $5.35 Million
Q1 2019 May 10, 2019	SELL	$37.5 - $41.2 $187,500 - $206,000	-5,000 Reduced 3.81%	126,190 $5.36 Million
Q4 2018 Feb 11, 2019	SELL	$38.47 - $43.86 $3,847 - $4,386	-100 Reduced 0.08%	131,190 $5.73 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $99,963 - $121,249	-2,900 Reduced 2.16%	131,290 $5.79 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $1.81 Million - $1.93 Million	-55,022 Reduced 29.08%	134,190 $4.87 Million
Q1 2018 May 09, 2018	SELL	$31.91 - $37.02 $2.39 Million - $2.77 Million	-74,902 Reduced 28.36%	189,212 $6.72 Million
Q4 2017 Feb 09, 2018	SELL	$33.26 - $35.29 $263,685 - $279,779	-7,928 Reduced 2.91%	264,114 $9.57 Million
Q3 2017 Nov 13, 2017	SELL	$31.0 - $34.15 $10,912 - $12,020	-352 Reduced 0.13%	272,042 $9.71 Million
Q2 2017 Aug 10, 2017	BUY	N/A	272,394	272,394 $9.15 Million

Others Institutions Holding PFE

# of Institutions

3,244

Shares Held

3.72B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $156B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilkins Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wilkins Investment Counsel Inc with notifications on news.

Account

Wilkins Investment Counsel Inc Pfizer Inc Transaction History